文献速递消化道出血肝病消化内镜

特利加压素联合头孢曲松2天与5天方案对急性胃食管静脉曲张出血5日再出血的非劣效性试验

A Noninferiority Trial Comparing 2 Days vs 5 Days of Terlipressin and Ceftriaxone in Terms of 5-Day Rebleeding for Patients With Acute Gastroesophageal Variceal Hemorrhage.
PubMed 文献 · Am J Gastroenterol · 2024-05-25

本试验将急性胃食管静脉曲张出血内镜止血成功后的患者随机分为两组,A组接受特利加压素1 mg每6小时一次联合头孢曲松1 g每日一次共5天,B组接受相同方案共2天。主要终点为5天内极早期再出血,B组非劣效于A组,且B组住院时间更短。

要点

  • 内镜止血成功后,2天特利加压素联合头孢曲松方案在5日极早期再出血方面非劣效于5天方案。
  • 48小时初始止血率A组95.8% vs B组100%(P=0.13),两组无显著差异。
  • 中位住院天数A组8.5±3.8天 vs B组5.6±2.6天(P<0.001),B组更短。

核心结论

  • 急性静脉曲张出血内镜止血成功后,2天特利加压素输注联合头孢曲松方案在极早期再出血方面非劣效于5天方案,且可缩短住院时间。

研究设计与样本

  • 随机对照非劣效性试验,纳入胃食管静脉曲张出血内镜止血成功的患者,A组48例接受5天方案,B组52例接受2天方案。

主要发现

  • 48小时初始止血率A组95.8% vs B组100%(P=0.13)。
  • 3至5天极早期再出血A组1例(2.1%)vs B组2例(3.8%)(P=0.60),差异1.8%,95%CI -1.31%至2.08%,证明非劣效。
  • 42天再出血A组5例(10.4%)vs B组4例(7.7%)(P=0.63)。
  • 中位住院天数A组8.5±3.8天 vs B组5.6±2.6天(P<0.001)。

关键数值与推荐

  • A组方案:特利加压素1 mg每6小时输注联合头孢曲松1 g每日一次,共5天。
  • B组方案:相同方案共2天。
  • 主要终点:5天极早期再出血;次要终点包括48小时止血、42天再出血和住院天数。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: This trial was to shorten the duration of both vasoconstrictors and prophylactic antibiotics to only 2 days in the therapy of acute gastroesophageal variceal hemorrhage. METHODS: After successful endoscopic hemostasis of gastroesophageal variceal hemorrhage, eligible patients were randomized to receive terlipressin infusion 1 mg per 6 hours and ceftriaxone 1 g daily for 5 days (group A) or a similar regimen for 2 days (group B). Primary end points were very early rebleeding at 5 days, and secondary end points included 48-hour hemostasis, 42-day rebleeding, and hospitalization days. RESULTS: Group A comprised 48 patients, and group B comprised 52 patients. Both groups were comparable in the severity of liver disease. Forty-eight-hour initial hemostasis was 95.8% in group A and 100% in group B ( P = 0.13). Very early rebleeding between 3 and 5 days occurred in 1 patient (2.1%) in group A and 2 patients (3.8%) in group B ( P = 0.60). The difference was 1.8% and the 95% confidence interval was -1.31% to 2.08%, which demonstrated noninferiority. Forty-two-day rebleeding occurred in 5 patients (10.4%) in group A and 4 patients (7.7%) in group B ( P = 0.63). The median hospitalization days were 8.5 ± 3.8 days in group A vs 5.6 ± 2.6 days in group B ( P < 0.001). DISCUSSION: After successful endoscopic hemostasis of acute variceal bleeding, combination of 2-day terlipressin infusion and ceftriaxone therapy was not inferior to the 5-day regimen in terms of very early rebleeding, with the advantage of shortening hospitalization stay.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Lo GH, Yeh JH, Tseng CH, et al. A Noninferiority Trial Comparing 2 Days vs 5 Days of Terlipressin and Ceftriaxone in Terms of 5-Day Rebleeding for Patients With Acute Gastroesophageal Variceal Hemorrhage. Am J Gastroenterol. 2024. PMID: 38526204. doi:10.14309/ajg.0000000000002776

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。